Rallybio Corporation
RLYB
$0.66
$0.011.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.71% | 154.52% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.71% | 154.52% | -- | -- | -- |
| Cost of Revenue | -50.07% | -64.34% | -72.32% | -52.87% | 7.86% |
| Gross Profit | 51.41% | 65.95% | 73.92% | 54.37% | -5.60% |
| SG&A Expenses | -18.93% | -21.05% | -28.76% | -27.82% | -27.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -42.15% | -40.56% | -33.51% | -26.73% | -10.16% |
| Operating Income | 42.64% | 41.35% | 34.61% | 27.54% | 10.96% |
| Income Before Tax | 78.84% | 43.62% | 36.83% | 22.52% | 5.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 78.84% | 43.62% | 36.83% | 22.52% | 5.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 78.84% | 43.62% | 36.83% | 22.52% | 5.04% |
| EBIT | 42.64% | 41.35% | 34.61% | 27.54% | 10.96% |
| EBITDA | 42.70% | 41.39% | 34.65% | 27.57% | 10.96% |
| EPS Basic | 79.93% | 47.84% | 42.38% | 27.36% | 11.75% |
| Normalized Basic EPS | 46.00% | 45.03% | 39.46% | 31.43% | 15.92% |
| EPS Diluted | 79.93% | 47.84% | 42.38% | 27.36% | 11.75% |
| Normalized Diluted EPS | 46.00% | 45.03% | 39.46% | 31.43% | 15.92% |
| Average Basic Shares Outstanding | 5.41% | 7.71% | 9.76% | 7.65% | 8.60% |
| Average Diluted Shares Outstanding | 5.41% | 7.71% | 9.76% | 7.65% | 8.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |